RAYNARD CASTILLO: Open Payments
NPI 1437586047 · FONTANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,303 in 69 payments from 9 companies in 2025. Trend: 2023 $992 · 2024 $1,665 · 2025 $2,303
Food & beverage: $2,303
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $410 |
| Vanda Pharmaceuticals Inc. | 7 | $371 |
| Alkermes, Inc. | 10 | $342 |
| ABBVIE INC. | 13 | $329 |
| Janssen Pharmaceuticals, Inc | 5 | $252 |
| Axsome Therapeutics, Inc. | 6 | $218 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $197 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| Almatica Pharma LLC | 4 | $86 |
Products named: COBENFY, VRAYLAR, INVEGA SUSTENNA, FANAPT, ARISTADA, Auvelity, CAPLYTA, HETLIOZ.
Industry payments across CA — which companies pay providers there.
